Products SEO & GEO Agent Paid Ads Agent Website Agent Conversion Agent
How it works Pricing FAQ Blog Book a call

Biotech SEO: compliant science pages first, then automation

Updated · 7 min read

Short answer Get the science pages right before you automate anything. A page may share trial findings but not call an unapproved product safe or effective, and research-use-only kits carry an FDA-required label. Google holds health pages to a higher bar. Then automate the routine work: reports, sitemaps, broken links. Keep every scientific claim with a human reviewer.

Want help applying this to your business? Talk it through on a free 30-minute call.

Book a call

Biotech SEO: the order that works

Compliance first, content second, automation last. Automating a page that makes an unlawful claim just publishes the claim faster.

StepWhat to doWhy first
1. ClaimsCheck every product page against FDA (US) or Health Canada rulesA ranking page with a banned claim is a liability, not an asset
2. Science pagesOne page per technology, product or program, with a named scientist behind itGoogle gives expertise extra weight on health topics
3. Searcher wordsPair each lab term with the words partners, investors and patients typeYour team's vocabulary is not your searchers'
4. MarkupOnly markup Google uses, such as DatasetMost science schema earns no special display in Google
5. AutomationReports, sitemaps, broken links, update alertsRoutine work with no claims in it

What can a biotech website say about a product in trials?

You can share the findings. You can't sell the product. The FDA rule for drugs under investigation:

"A sponsor or investigator, or any person acting on behalf of a sponsor or investigator, shall not represent in a promotional context that an investigational new drug is safe or effective for the purposes for which it is under investigation or otherwise promote the drug." (21 CFR 312.7)

The same section says it is "not intended to restrict the full exchange of scientific information concerning the drug, including dissemination of scientific findings in scientific or lay media" (21 CFR 312.7). Devices have a parallel rule: no promoting an investigational device until FDA approves it, and no saying it is safe or effective for the use under study (21 CFR 812.7).

For SEO this means a pipeline page can rank for "[target] Phase 2 trial" with the design, endpoints and published results. It shouldn't target "best treatment for [disease]" or use words like "proven" or "safe" about the candidate.

Canada. The Food and Drug Regulations say "No person shall sell or advertise a new drug unless" the manufacturer has filed a submission satisfactory to the Minister and been authorized (C.08.002). Once a prescription drug is approved, ads to the public may mention only "the brand name, the proper name, the common name and the price and quantity of the drug" (C.01.044). Class II to IV medical devices can't be advertised for sale before the manufacturer holds a licence or authorization, except in a catalogue warning that the devices may not be licensed (Medical Devices Regulations, s. 27).

Research-use-only products: the label your page must match

Reagents and kits still in the lab research phase are exempt from full diagnostic labeling only if "all labeling" carries, prominently:

"For Research Use Only. Not for use in diagnostic procedures." (21 CFR 809.10(c)(2)(i))

And only while the product is "not represented as an effective in vitro diagnostic product" (same section). So a research-use-only kit page that targets "[disease] diagnostic test" works against its own label. Target the research application instead: "[analyte] ELISA kit for mouse serum", "[method] reagent".

Keywords: lab words vs searcher words

Each audience types different words for the same science. Build one page per audience need, not one page for everyone.

Who searchesTypical searchPage that answers it
Lab scientist"[method] protocol", "[analyte] antibody validated for IHC"Product or application page with specs and data
Pharma partner"[modality] platform licensing", "[target] program"Platform or pipeline page
Investor or journalist"[company] pipeline", "[company] Phase 1 results"Pipeline and news pages
Patient or family"[disease] clinical trial near me"Trial page with sites and eligibility, no efficacy claims
Job seeker"[city] biotech jobs"Careers page

How to find the volume behind each term with free tools: keyword research. The method is the same; only the vocabulary changes.

How Google judges biotech pages

More strictly than most. Google says its "systems give even more weight to content that aligns with strong E-E-A-T" on topics affecting health or safety, which it calls "Your Money or Your Life" topics (Google Search Central). And:

"For topics that could significantly impact people's lives or well-being (YMYL topics), the content must be highly accurate and consistent with established expert consensus." (Google Search Central)

In practice: name the scientist who wrote or reviewed each science page, link their publications, cite the papers and trial registrations you rely on, and date the page. What E-E-A-T means and how to show it: E-E-A-T for a small business.

Schema for biotech: what Google actually uses

Less than many guides claim. Google's structured data gallery lists 25 features. None of them is for scholarly articles, medical studies or medical conditions (Google Search Central). Adding that schema may describe your page, but it earns no special display in Google.

The one that fits biotech is Dataset. Google: "Datasets are easier to find in the Dataset Search tool when you provide supporting information such as their name, description, creator and distribution formats as structured data" (Google Search Central). If you publish open data, mark up each dataset's landing page. Organization and Article markup also apply, as for any company.

Does a biotech website need to be HIPAA compliant?

Usually not, unless you are a covered entity or work for one. HIPAA applies to health plans, clearinghouses, and "a health care provider who transmits any health information in electronic form in connection with a transaction covered by this subchapter," plus their business associates (45 CFR 160.102). A drug developer or reagent maker usually isn't one. A clinical lab that bills insurers may be, and then tracking pixels on its site are a real risk: tracking and HIPAA. Trial-recruitment forms still collect health data, so ask only what screening needs.

From the places scientists already cite. Ask for a link where your work is named: papers whose methods sections use your product, collaborators' lab and university pages, conference poster and talk pages, and data repositories that host your datasets. A useful method page or open dataset earns links on its own. Google's spam policies list "Buying or selling links for ranking purposes" as link spam (Google Search Central). More: backlinks without a penalty.

Which biotech SEO work to automate

Automate what has no scientific claim in it. Keep a human on everything that does.

AutomateKeep a human on
Weekly search reports: the Search Console API lets you "Query your search analytics" and "manage your sitemaps" (Google)Any sentence about what a product does or how well
Sitemap updates when a page is addedPipeline and trial pages
Broken link and redirect checksResearch-use-only and investigational wording
Alerts when a page's clicks fall, so it gets reviewedTitles and meta descriptions on product pages
First drafts of glossary or method explainers, for a scientist to checkFinal sign-off before publishing

Google's rule for AI writing is the reason for the right column:

"It is critical to manually factcheck and review all AI-generated content for accuracy and trustworthiness before publishing." (Google Search Central)

Google adds that the review covers page titles and meta descriptions too (same page). And mass production backfires: Google's spam policies name "Using generative AI tools or other similar tools to generate many pages without adding value for users" as scaled content abuse (Google Search Central). More on where AI helps and where it doesn't: can AI do SEO and does Google penalize AI content.

Example

A 12-person reagent company

It sells 300 antibodies, all labeled for research use only. It writes one page per antibody with the validated applications and data images, and targets "[target] antibody for western blot", never diagnostic terms. A script checks weekly for broken links and new pages missing from the sitemap. A scientist approves each new page.

A clinical-stage drug developer

Its lead candidate is in Phase 2. The pipeline page names the target, trial design and registry number, and links the published Phase 1 paper. It ranks for "[target] inhibitor Phase 2". It doesn't say the drug works. An automated report flags when trial pages lose clicks, so the team checks they're current.

A Canadian diagnostics startup

Its Class II test isn't licensed yet. Its site explains the technology and the validation study, and has an investor page. The product page with pricing and "order now" waits until the licence is issued.

FAQ

Can we post trial results on our website?

Yes. FDA allows sharing scientific findings, but not promoting an investigational drug as safe or effective (21 CFR 312.7). Borderline wording goes to regulatory counsel.

Does schema markup get biotech pages rich results?

Only for features in Google's gallery. Dataset fits most biotech sites; none exists for scholarly articles or medical studies (Google Search Central).

Can AI write our science pages?

It can draft them. Google says to fact-check all AI content before publishing (Google Search Central), and expects health content to match expert consensus.

How long does biotech SEO take?

As long as SEO for any new site. Niche technical terms often have less competition, but fewer searches. See how long SEO takes.

Different for you?

Keep learning

NextB2B tech content: how to earn the trust of every buyer in a dealB2B tech content for each person who signs off on a software deal: user, engineer, security, finance, legal and executive, and the proof each one needs.

Ask us one question

One line is enough. We reply by email.

Sources

  1. 21 CFR 312.7: Promotion of investigational drugs (eCFR)
  2. 21 CFR 812.7: Prohibition of promotion and other practices (eCFR)
  3. 21 CFR 809.10: Labeling for in vitro diagnostic products (eCFR)
  4. Food and Drug Regulations, C.08.002 (Justice Laws)
  5. Food and Drug Regulations, C.01.044 (Justice Laws)
  6. Medical Devices Regulations, section 27 (Justice Laws)
  7. 45 CFR 160.102: HIPAA applicability (eCFR)
  8. Google Search Central: Creating helpful, reliable, people-first content
  9. Google Search Central: Using generative AI content on your website
  10. Google Search Central: Spam policies for Google web search
  11. Google Search Central: Structured data search gallery
  12. Google Search Central: Dataset structured data
  13. Google Search Console API